Sample size reestimation by Bayesian prediction
- PMID: 17623342
- DOI: 10.1002/bimj.200310273
Sample size reestimation by Bayesian prediction
Abstract
We review a Bayesian predictive approach for interim data monitoring and propose its application to interim sample size reestimation for clinical trials. Based on interim data, this approach predicts how the sample size of a clinical trial needs to be adjusted so as to claim a success at the conclusion of the trial with an expected probability. The method is compared with predictive power and conditional power approaches using clinical trial data. Advantages of this approach over the others are discussed.
Similar articles
-
Stopping boundaries adjusted for sample size reestimation and negative stop.J Biopharm Stat. 2002 Nov;12(4):485-502. doi: 10.1081/BIP-120016232. J Biopharm Stat. 2002. PMID: 12477071
-
Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.Stat Med. 2009 Jul 30;28(17):2185-201. doi: 10.1002/sim.3609. Stat Med. 2009. PMID: 19462415
-
Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.Contemp Clin Trials. 2008 Jul;29(4):507-16. doi: 10.1016/j.cct.2007.12.001. Epub 2007 Dec 23. Contemp Clin Trials. 2008. PMID: 18201944 Review.
-
Sample size determination for phase II clinical trials based on Bayesian decision theory.Biometrics. 1998 Mar;54(1):279-94. Biometrics. 1998. PMID: 9544522
-
Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.Control Clin Trials. 2004 Apr;25(2):157-67. doi: 10.1016/j.cct.2003.11.006. Control Clin Trials. 2004. PMID: 15020034 Review.
Cited by
-
Guidance on interim analysis methods in clinical trials.J Clin Transl Sci. 2023 May 15;7(1):e124. doi: 10.1017/cts.2023.552. eCollection 2023. J Clin Transl Sci. 2023. PMID: 37313374 Free PMC article. Review.
-
Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis.Front Pharmacol. 2025 Mar 25;16:1548997. doi: 10.3389/fphar.2025.1548997. eCollection 2025. Front Pharmacol. 2025. PMID: 40201693 Free PMC article.
-
A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials.Contemp Clin Trials. 2013 Nov;36(2):587-96. doi: 10.1016/j.cct.2013.03.011. Epub 2013 Apr 11. Contemp Clin Trials. 2013. PMID: 23583925 Free PMC article.
-
The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study.Pediatr Crit Care Med. 2013 May;14(4):374-83. doi: 10.1097/PCC.0b013e318274568c. Pediatr Crit Care Med. 2013. PMID: 23392377 Free PMC article.
-
Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.CJC Open. 2023 Jul 13;5(8):611-618. doi: 10.1016/j.cjco.2023.05.009. eCollection 2023 Aug. CJC Open. 2023. PMID: 37720184 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical